Last edition
News about "metabolic diseases "
Novo Nordisk to Acquire Akero Therapeutics Alongside Promising MASH Therapy Efruxifermin
Danish pharma giant Novo Nordisk has signed a definitive agreement to acquire Akero Therapeutics, a San Francisco-based clinical-stage biopharmaceutical company focused on developing innovative therapies for serious metabolic diseases.
Metabolic Diseases | 10/10/2025 | By Dineshwori
Sciwind Signs Global Licensing Deal with Verdiva for Metabolic Disease Portfolio
Sciwind has granted Verdiva the exclusive global rights to develop, manufacture and commercialize the partnered programs outside of greater China and South Korea.
Metabolic Diseases | 13/01/2025 | By Aishwarya | 235
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy